FDA OKs new label expansions for Dupixent and Incyte's Monjuvi
Plus, news about Novartis' Mariana Oncology: FDA approves Dupixent in rare autoimmune disease: The approval is for bullous pemphigoid, a condition in which the immune system attacks ...

Jun 20, 2025 0
Jun 20, 2025 0
Jun 20, 2025 0
Jun 20, 2025 0
Jun 20, 2025 0
Jun 20, 2025 0
Jun 20, 2025 0
Or register with email
Apr 26, 2025 0
Jun 2, 2025 0
May 12, 2025 0
Jun 6, 2025 0
Jun 9, 2025 0
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.